Palatin is a New Jersey biopharmaceutical company developing peptide and small molecule medicines that target melanocortin receptors. It last closed at $4.58 on Nov 20, down 7.10% on the day. For the quarter ended Sep 2026, PTN reported EPS of -$1.29 on revenue of $361,802, with revenue down 95.9% from a year ago. Over the last 12 months PTN insiders bought $0 of stock on the open market and sold $9K, according to SEC Form 4 filings.
AI Auto Pilots
Is PTN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PTN.
StreetAlpha's call on PTNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PTN · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 23% below its 20 day and 64% below its 50 day average. It is 189% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 32), near oversold. The nearest support is the 52 week low at $4.51, and the nearest resistance the Pivot at $4.73.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 15.0%/day
Key levels
$31.0052 week high+576.9%
$13.25200 day average+189.3%
$8.59100 day average+87.6%
$7.5050 day average+63.8%
$7.33Swing high (Nov 9)+60.0%
$5.6420 day average+23.1%
$4.89Pivot R1+6.8%
$4.73Pivot+3.3%
$4.58Last close
$4.5152 week low−1.5%
$4.51Swing low (Oct 28)−1.5%
$4.41Pivot S1−3.7%
Indicators
RSI (14)
32.01
Weak, oversold below 30
Neutral
MACD
-0.54
Below its signal line
Bearish
Stochastic
7.5
Near the bottom of its range
Oversold
ADX (14)
25.4
Trending down
Williams %R
-99.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-93.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−26.9%
Change over 10 sessions
Bearish
ATR (14)
$0.69
Typical daily range, 15.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, nearing oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityHigh, 51.8%/day
Key levels
$31.0052 week high+576.9%
$13.25200 day average+189.3%
$8.59100 day average+87.6%
$7.5050 day average+63.8%
$7.33Swing high (Nov 9)+60.0%
$5.6420 day average+23.1%
$4.89Pivot R1+6.8%
$4.73Pivot+3.3%
$4.58Last close
$4.5152 week low−1.5%
$4.51Swing low (Oct 28)−1.5%
$4.41Pivot S1−3.7%
Indicators
RSI (14)
34.12
Weak, oversold below 30
Neutral
MACD
-2.36
Below its signal line
Bearish
Stochastic
12.5
Near the bottom of its range
Oversold
ADX (14)
19.2
No clear trend
Williams %R
-99.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-123.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−61.2%
Change over 10 sessions
Bearish
ATR (14)
$2.37
Typical daily range, 51.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for PTN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PTN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow PTN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PTNHow many large options trades hit PTN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PTN in the last 90 days.
From SEC Form 4 filings by PTN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PTN is in one of them and how their past PTN trades turned out.
Palatin is a biopharmaceutical company based in Cranbury, New Jersey. It develops drug candidates that act on the melanocortin receptor system, a group of receptors involved in inflammation, immune response, appetite and metabolism. Its main focus is treatments for obesity and rare diseases tied to this pathway, with other candidates aimed at eye, gut and immune conditions. The company generally works with pharmaceutical partners to license and commercialize its products.